We advised the InMedica medical clinic network on issuing bonds for listing on First North, an alternative securities market administered by Nasdaq Vilnius. We are also InMedica Certified Advisor on the First North market in Lithuania.
In total, InMedica borrowed EUR 8 million over two years at an annual interest rate of 5%. The bonds were purchased by 144 investors.
Attracted new investors
The main purpose is to refinance the company’s previous bond emission, which had a total value of EUR 5 million, while the remaining funds will be used to promote the growth of its clinic network.
“This is our second emission, which illustrates the trust we gained from investors. The initial expectation was to have a sizeable part reinvested from existing investors, replacing old bonds by new ones, but we are happy to have received significant attention from new investors. This proves that investors feel positive about the outlook for InMedica, which enables us to continue our successful path in the capital markets,” says Kęstutis Broniukaitis, CEO at InMedica.
Our services and team
We advised the client on preparing the company description to ensure that it meets requirements, and advised on preparing and filing an application to admit the bonds to trading on the First North bond market.
The client was advised by senior associate Dalia Augaitė and associate Eglė Martinaitytė.
